Oric Pharmaceuticals
ORIC
12.01
+0.03
+0.25%
Oric Pharmaceuticals
US · ORIC
#3089 by market cap
Listed 2020
12.01
+0.03
+0.25%
Live - 5344 symbols - heartbeat 467s ago
· 2026-10-08 08:24
Pre-market
11.81
-1.67%
After-hours
12.01
0.00%
- Market cap
- 1.24B
- P/E (TTM)i
- -9.24
- P/Bi
- 3.27
- EPSi
- -1.47
- Div yieldi
- 0.00%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on ORIC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.7 percentage points.
Institutional ownership
- Held by institutions
- 120.01% -2.68pp
- Institutions
- 207 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund42.60%
Hedge Fund38.73%
VC/PE Fund31.52%
Public Company4.97%
Individual/Insider1.04%
Family Office/Trust0.99%
Private Company0.93%
Government Pension Fund0.16%
Top holders as of 2026-06-30
Nextech Invest Ltd.
6.91% · 7.16M sh
BlackRock
6.58% · 6.82M sh
EcoR1 Capital, LLC
6.49% · 6.73M sh
T. Rowe Price Group, Inc.
6.38% · 6.62M sh
Viking Global Investors LP
4.95% · 5.13M sh
State Street Global Advisors
4.72% · 4.89M sh
SR One Capital Management, LP
4.45% · 4.62M sh
Vanguard Capital Management, LLC
4.36% · 4.52M sh
VR Management, LLC
4.17% · 4.32M sh
New Enterprise Associates, Inc.
3.97% · 4.12M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 26 sells
| Name | Role | Stake |
|---|---|---|
| Jacob Chacko | Chief Executive Officer | 0.56% |
| Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | 0.24% |
| Lori Kunkel | Independent Director | 0.08% |
| Dominic Piscitelli | Chief Financial Officer | 0.07% |
| Pratik Multani | Chief Medical Officer | 0.07% |
| Angie You | Independent Director | 0.03% |
| Mardi Dier | Independent Director | -- |
| Steven Hoerter | Indepdnent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -3,200 | $12.91 |
| 2026-09-30 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Derivative Exercise and Sale | -3,500 | $1.60–12.91 |
| 2026-09-27 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -13,400 | $4.36–13.53 |
| 2026-09-23 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -600 | $4.36–13.51 |
| 2026-08-25 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -77,000 | $4.36–13.69 |
| 2026-07-23 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Open Market Disposition | -9,600 | $12.02 |
| 2026-07-23 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Derivative Exercise and Sale | -3,500 | $1.60–12.02 |
| 2026-07-05 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -300 | $12.00 |
| 2026-02-23 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -52,000 | $4.36–13.51 |
| 2026-01-15 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -6,700 | $12.00 |
| 2026-01-01 | Pratik Multani | Chief Medical Officer | Other Derivative Acquisition | +35,500 | -- |
| 2026-01-01 | Pratik Multani | Chief Medical Officer | Other Derivative Acquisition | +214,000 | $8.17 |
| 2026-01-01 | Angie You | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 |
| 2026-01-01 | Richard Heyman | Co-Founder, Independent Chairman & Member of Scientific Advisory Board | Other Derivative Acquisition | +40,000 | $8.17 |
| 2026-01-01 | Lori Kunkel | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 |
| 2026-01-01 | Mardi Dier | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 |
| 2026-01-01 | Jacob Chacko | Chief Executive Officer | Other Derivative Acquisition | +112,500 | -- |
| 2026-01-01 | Jacob Chacko | Chief Executive Officer | Other Derivative Acquisition | +675,000 | $8.17 |
| 2026-01-01 | Steven Hoerter | Indepdnent Director | Other Derivative Acquisition | +40,000 | $8.17 |
| 2026-01-01 | Dominic Piscitelli | Chief Financial Officer | Other Derivative Acquisition | +34,500 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:24:08 · For reference only, not investment advice and not tailored to your situation.